These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. OMERACT endorsement of measures of outcome for studies of acute gout. Singh JA; Taylor WJ; Dalbeth N; Simon LS; Sundy J; Grainger R; Alten R; March L; Strand V; Wells G; Khanna D; McQueen F; Schlesinger N; Boonen A; Boers M; Saag KG; Schumacher HR; Edwards NL J Rheumatol; 2014 Mar; 41(3):569-73. PubMed ID: 24334651 [TBL] [Abstract][Full Text] [Related]
8. Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensus. Bartlett SJ; Hewlett S; Bingham CO; Woodworth TG; Alten R; Pohl C; Choy EH; Sanderson T; Boonen A; Bykerk V; Leong AL; Strand V; Furst DE; Christensen R; Ann Rheum Dis; 2012 Nov; 71(11):1855-60. PubMed ID: 22772326 [TBL] [Abstract][Full Text] [Related]
9. A Preliminary Core Domain Set for Clinical Trials of Shoulder Disorders: A Report from the OMERACT 2016 Shoulder Core Outcome Set Special Interest Group. Buchbinder R; Page MJ; Huang H; Verhagen AP; Beaton D; Kopkow C; Lenza M; Jain NB; Richards B; Richards P; Voshaar M; van der Windt D; Gagnier JJ; J Rheumatol; 2017 Dec; 44(12):1880-1883. PubMed ID: 28089972 [TBL] [Abstract][Full Text] [Related]
10. Toward a valid definition of gout flare: results of consensus exercises using Delphi methodology and cognitive mapping. Taylor WJ; Shewchuk R; Saag KG; Schumacher HR; Singh JA; Grainger R; Edwards NL; Bardin T; Waltrip RW; Simon LS; Burgos-Vargas R Arthritis Rheum; 2009 Apr; 61(4):535-43. PubMed ID: 19333981 [TBL] [Abstract][Full Text] [Related]
11. Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol. Kelly A; Tong A; Tymms K; March L; Craig JC; De Vera M; Evans V; Hassett G; Toupin-April K; van den Bemt B; Teixeira-Pinto A; Alten R; Bartlett SJ; Campbell W; Dawson T; Gill M; Hebing R; Meara A; Nieuwlaat R; Shaw Y; Singh JA; Suarez-Almazor M; Sumpton D; Wong P; Christensen R; Beaton D; de Wit M; Tugwell P; Trials; 2018 Mar; 19(1):204. PubMed ID: 29587864 [TBL] [Abstract][Full Text] [Related]
12. Improvement in OMERACT domains and renal function with regular treatment for gout: a 12-month follow-up cohort study. Vazquez-Mellado J; Peláez-Ballestas I; Burgos-Vargas R; Alvarez-Hernández E; García-Méndez S; Pascual-Ramos V; Rull-Gabayet M Clin Rheumatol; 2018 Jul; 37(7):1885-1894. PubMed ID: 29546696 [TBL] [Abstract][Full Text] [Related]
13. Serum urate in chronic gout--will it be the first validated soluble biomarker in rheumatology? Stamp LK; Khanna PP; Dalbeth N; Boers M; Maksymowych WP; Schumacher HR; Becker MA; MacDonald PA; Edwards NL; Singh JA; Simon LS; McQueen FM; Neogi T; Gaffo AL; Strand V; Taylor WJ J Rheumatol; 2011 Jul; 38(7):1462-6. PubMed ID: 21724717 [TBL] [Abstract][Full Text] [Related]
14. Serum urate as a soluble biomarker in chronic gout-evidence that serum urate fulfills the OMERACT validation criteria for soluble biomarkers. Stamp LK; Zhu X; Dalbeth N; Jordan S; Edwards NL; Taylor W Semin Arthritis Rheum; 2011 Jun; 40(6):483-500. PubMed ID: 21056459 [TBL] [Abstract][Full Text] [Related]
15. Quality of care indicators for gout management. Mikuls TR; MacLean CH; Olivieri J; Patino F; Allison JJ; Farrar JT; Bilker WB; Saag KG Arthritis Rheum; 2004 Mar; 50(3):937-43. PubMed ID: 15022337 [TBL] [Abstract][Full Text] [Related]
16. Patient-reported outcomes in chronic gout: a report from OMERACT 10. Singh JA; Taylor WJ; Simon LS; Khanna PP; Stamp LK; McQueen FM; Neogi T; Gaffo AL; Becker MA; MacDonald PA; Dabbous O; Strand V; Dalbeth ND; Aletaha D; Edwards NL; Schumacher HR J Rheumatol; 2011 Jul; 38(7):1452-7. PubMed ID: 21724715 [TBL] [Abstract][Full Text] [Related]
17. Consensus-based semi-quantitative ultrasound scoring system for gout lesions: Results of an OMERACT Delphi process and web-reliability exercise. Christiansen SN; Filippou G; Scirè CA; Balint PV; Bruyn GA; Dalbeth N; Dejaco C; Sedie AD; Filippucci E; Hammer HB; Iagnocco A; Keen HI; Kissin EY; Koski J; Mandl P; Martin J; Miguel E; Möller I; Naredo E; Pineda C; Schmidt WA; Stewart S; Antonietta D'Agostino M; Terslev L; Semin Arthritis Rheum; 2021 Jun; 51(3):644-649. PubMed ID: 33468347 [TBL] [Abstract][Full Text] [Related]
18. Outcomes assessed in trials of gout and accordance with OMERACT-proposed domains: a systematic literature review. Araújo F; Cordeiro I; Ramiro S; Falzon L; Branco JC; Buchbinder R Rheumatology (Oxford); 2015 Jun; 54(6):981-93. PubMed ID: 25398382 [TBL] [Abstract][Full Text] [Related]
19. Outcome measures in acute gout: a systematic literature review. Dalbeth N; Zhong CS; Grainger R; Khanna D; Khanna PP; Singh JA; McQueen FM; Taylor WJ J Rheumatol; 2014 Mar; 41(3):558-68. PubMed ID: 24334652 [TBL] [Abstract][Full Text] [Related]
20. Application of the OMERACT filter to measures of core outcome domains in recent clinical studies of acute gout. Taylor WJ; Redden D; Dalbeth N; Schumacher HR; Edwards NL; Simon LS; John MR; Essex MN; Watson DJ; Evans R; Rome K; Singh JA J Rheumatol; 2014 Mar; 41(3):574-80. PubMed ID: 24429178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]